AN2 Therapeutics, Inc.
SEC CIK 1880438 · ANTX · last insider filing 2026-06-02
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Aziz Kabeer | Director | filed 2022 - 2026 |
| Martin Patricia A. | Director | filed 2022 - 2026 |
| Marks Gilbert Lynn | Director | filed 2022 - 2026 |
| Zakrzewski Joseph S | Director | filed 2022 - 2026 |
| Spigelman Melvin K | Director | filed 2022 - 2026 |
| Wong Stephanie | Director | filed 2022 - 2026 |
| Fitzpatrick Margaret M | Director | filed 2022 - 2026 |
| Easom Eric | Director · Chief Executive Officer | filed 2022 - 2026 |
| Readnour Robin Shane | Director | filed 2022 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Williams Sarah Joanne | Principal Accounting Officer | filed 2026 - 2026 |
| Chanda Sanjay | Chief Development Officer | filed 2022 - 2026 |
| Day Lucy | Chief Financial Officer | filed 2022 - 2026 |
| Eizen Joshua M | See Remarks | filed 2022 - 2026 |
| Prior Stephen David | Chief Strategy Officer | filed 2024 - 2026 |
| Eckburg Paul | Chief Medical Officer | filed 2022 - 2024 |
| Krause Kevin Michael | Chief Strategy Officer | filed 2022 - 2024 |
| Nazak Michael Adrian | Chief Accounting Officer | filed 2022 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.